PCI also inhibits proteases of the blood coagulation and fibrinolysis system, whilst in cancer cells it suppresses tumor invasion by inhibiting urokinase-type plasminogen activators and inhibits tumor growth and metastasis, which are independent of its protease-inhibitory activity [86]. The gene discussed is PLAU; the disease is cancer.